數位 PCR (dPCR) 和即時PCR(qPCR) 市場規模、佔有率、成長分析，按技術、按產品、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年，全球數位PCR（dPCR）和即時PCR （qPCR）市場規模為101億美元，在預測期內（2025-2032年）預計複合年成長率為8.1%，到2024年將達到109.2億美元。到2032年將從203.6億美元成長到203.6億美元。

由於遺傳性感染疾病病率的上升以及 PCR 技術的進步，即時PCR和數位 PCR 市場正在顯著成長。即時PCR被廣泛認為是一種快速、靈敏的定量各種生物樣本中核酸的方法。相較之下，數位 PCR 透過將樣本分成數千個單獨的反應來提供準確的定量，就像 Droplet Digital(TM) PCR 技術中的液滴一樣。儘管這些技術對於測量微小的基因突變至關重要，並且可用於各種法醫學和實驗室應用，但固有的技術限制和疾病檢測替代分析的日益使用限制了市場的成長。總體而言，儘管存在這些障礙，dPCR 和 qPCR 市場的未來看起來還是充滿希望的。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管分析
• 案例研究分析
• 專利分析
• 技術分析

按技術分類的數位 PCR (dPCR) 和即時PCR(qPCR) 市場規模

• 市場概況
• 定量PCR
• 數位PCR

數位 PCR (dPCR) 和即時PCR(qPCR) 市場規模：按產品分類

• 市場概況
• 試劑及耗材
• 裝置
• 軟體

按應用分類的數位 PCR (dPCR) 和即時PCR(qPCR) 市場規模

• 市場概況
• 臨床應用
  • 病原體檢測
  • 腫瘤檢查
  • 驗血
  • 其他臨床應用
• 調查申請
• 法醫學應用

最終用戶的數位 PCR (dPCR) 和即時PCR(qPCR) 市場規模

• 市場概況
• 醫院和診斷中心
• 研究實驗室和學術機構
• 製藥和生物技術公司
• 臨床研究組織
• 法醫學研究所

數位 PCR (dPCR) 和即時PCR(qPCR) 市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Danaher Corporation（US）
• Bio-Rad Laboratories, Inc.（US）
• Merck KGaA（Germany）
• Becton, Dickinson and Company（US）
• Abbott Laboratories（US）
• Qiagen NV（Germany）
• Thermo Fisher Scientific, Inc.（US）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Takara Bio, Inc.（Japan）
• Agilent Technologies, Inc.（US）
• GE Healthcare（US）
• bioMerieux（France）
• Fluidigm Corporation（US）
• Roche Diagnostics（Switzerland）
• Illumina, Inc.（US）
• Siemens Healthineers（Germany）
• PerkinElmer, Inc.（US）
• LGC Limited（UK）
• Bio-Techne Corporation（US）
• Cambridge Epigenetix Ltd.（UK）

結論和建議

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market size was valued at USD 10.1 billion in 2023 and is poised to grow from USD 10.92 billion in 2024 to USD 20.36 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The real-time PCR and digital PCR markets are experiencing significant growth driven by the rising prevalence of genetic and infectious diseases, as well as advancements in PCR technology. Real-time PCR is a widely recognized method for the rapid and sensitive quantification of nucleic acids in diverse biological samples. In contrast, digital PCR offers precise quantification by partitioning samples into thousands of individual reactions, such as droplets in Droplet Digital(TM) PCR technology. While these techniques are integral for measuring minor genetic variants and serve various applications in forensic and research laboratories, market growth may face challenges due to inherent technical limitations and the increasing use of alternative assays for disease detection. Overall, the future of the dPCR and qPCR market appears promising despite these hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market Segmental Analysis

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is segmented by technology, product, application, end user and region. Based on technology, the market is segmented into quantitative PCR and digital PCR. Based on product, the market is segmented into reagents and consumables, instruments and software. Based on application, the market is segmented into clinical applications, research applications and forensic applications. Based on end user, the market is segmented into hospitals & diagnostic centers, research laboratories & academic institutes, pharmaceutical & biotechnology companies, clinical research organizations & forensic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market

The global digital PCR (dPCR) and real-time PCR (qPCR) market is poised for expansion due to several key drivers. The rising incidence of infectious diseases is expected to significantly enhance the demand for these advanced diagnostic technologies. Additionally, the growing prevalence of genetic disorders highlights the need for precise and efficient testing methods, further fueling market growth. The successful completion of the Human Genome Project has also paved the way for advancements in genetic research and diagnostics, creating a broader application scope for dPCR and qPCR technologies. Collectively, these factors are set to propel the market forward in the coming years.

Restraints in the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market

The global Digital PCR (dPCR) and Real-Time PCR (qPCR) market faces several restraints that could impede its growth during the forecast period. Specific technical challenges inherent in dPCR and qPCR procedures, such as difficulties in accurately measuring signals during the exponential phase of the PCR reaction, as well as the necessity for extensive optimization and validation of assay protocols, can lead to limitations in target detection. These constraints may result in failures when examining target molecules, ultimately affecting the efficiency and reliability of these techniques. Consequently, these technical issues pose significant challenges that may restrict market expansion.

Market Trends of the Global Digital Pcr (Dpcr) And Real-Time Pcr (Qpcr) Market

The Global Digital PCR (dPCR) and Real-Time PCR (qPCR) market is witnessing significant growth, driven largely by rising viral infections and a pressing need for advanced diagnostic solutions. The escalating focus on precision medicine and personalized treatment is propelling the adoption of digital PCR technologies, especially in identifying novel drug targets and biomarkers for viral diseases and rare cancers. Enhanced sensitivity and specificity of digital droplet PCR (ddPCR) are amplifying its utility in tumor profiling and biomarker discovery, thereby attracting increased investment in research and development. This trend underscores a pivotal shift in healthcare innovation aimed at improving patient outcomes through cutting-edge molecular diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Case Study Analysis
• Patent Analysis
• Technology Analysis

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Quantitative PCR
• Digital PCR

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents And Consumables
• Instruments
• Software

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Applications
  • Pathogen Testing
  • Oncology Testing
  • Blood Screening
  • Other Clinical Applications
• Research Applications
• Forensic Applications

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals And Diagnostic Centers
• Research Laboratories & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market Size & CAGR (2025-2032)

• North America (Technology, Product, Application, End User)
  • US
  • Canada
• Europe (Technology, Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambridge Epigenetix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations